Renee Gala
President and Chief Executive Officer
Jazz Pharmaceuticals
Pamela Gavin
Chief Executive Officer
NORD
Alexander Hardy
President and Chief Executive Officer
BioMarin Pharmaceutical
Beth Kozel, MD, PhD
Chief of the Division of Genetics and Genomic Medicine and the Director of Constitutional Genomics Translational Research
Nationwide Children's Hospital, a NORD Rare Disease Center of Excellence
Martin Mackay, PhD
Co-Founder & Chair
RallyBio
Sean Nolan
Chief Executive Officer
Taysha Gene Therapies
Tarek Rabah, MBA
President and Chief Executive Officer
Otsuka North America Pharmaceutical Business
Debra Regier, MD, PhD
Director
Ward Winslett Center for Rare Diseases, Atrium Health Levine Children's Hospital, a NORD Rare Disease Center of Excellence
Camille Samuels
Board Member
The Ehlers Danlos Society, formerly with Venrock/Versant
David Scheer
President
Scheer & Company, Inc.
Stephen Squinto, PhD
Chief Investment Officer
J.P. Morgan Life Science Private Capital
Uthra Sundaram
Senior Vice President, Business Unit Head
USBU Foundational Therapeutics Platform (FTP); Takeda Pharmaceuticals U.S.A., Inc.
V. Reid Sutton, MD
Professor of Molecular & Human Genetics
Baylor College of Medicine & Texas Children’s Hospital, a NORD Rare Disease Center of Excellence
Jasper van Grunsven
Senior Vice President, Rare Disease & Global Commercial Capabilities and Innovation
Amgen